Sandler Alan B. sold $68K of RVMD
Sandler Alan B. (Chief Development Officer) sold 341 shares of Revolution Medicines, Inc. (RVMD) at an average of $199.24 ($194.96–$199.30) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is routine and unlikely to move the stock.
Market read
Minor insider transaction with limited trading relevance.
What to watch
Potential future sales under the 10b5‑1 plan could accumulate.
Background
Form 4 filings disclose insider transactions; traders monitor large sales for signals.
Ticker impact
Chief Development Officer sold 341 shares for $67,941 via a 10b5‑1 plan on 2026‑09‑16.
No significant move expected.
The transaction size is trivial relative to market cap and was pre‑arranged.
Market effects
None; biotech sector not affected by a minor insider sale.
No regional effect.
None.
Counterpoint
Even small insider sales can signal confidence issues, but size here is negligible.
Key entities
- personSandler Alan B.
Chief Development Officer of Revolution Medicines, Inc.
